Mesoblast (MESO) FCF Margin (QoQ) (2017 - 2023)
Mesoblast (MESO) FCF Margin (QoQ) (2017 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
121,826.00 |
| Mar 31, 2023 |
705.00 |
| Dec 31, 2022 |
-15,908.00 |
| Sep 30, 2022 |
445,505.00 |
| Jun 30, 2022 |
-423,423.00 |
| Mar 31, 2022 |
153,413.00 |
| Dec 31, 2021 |
-151,627.00 |
| Sep 30, 2021 |
989,860.00 |
| Jun 30, 2021 |
-1.63 Mn |
| Mar 31, 2021 |
847,320.00 |
| Dec 31, 2020 |
79,382.00 |
| Sep 30, 2020 |
-182,599.00 |
| Jun 30, 2020 |
-128,843.00 |
| Mar 31, 2020 |
88,848.00 |
| Dec 31, 2019 |
-76,354.00 |
| Sep 30, 2019 |
573,673.00 |
| Jun 30, 2019 |
-693,914.00 |
| Mar 31, 2019 |
220,021.00 |
| Dec 31, 2018 |
-210,946.00 |
| Sep 30, 2018 |
958,016.00 |
